Darzalex, which treats multiple myeloma, has become the first Johnson & Johnson drug to ever top $3 billion in quarterly ...

The plaintiff filed a motion for a new trial, arguing that, “At a minimum, the verdict shows confusion and lack of ...

An OB/GYN was terse in her feedback, saying she needed an answer to inquiries from patients on whether their ovarian cancer ...

J&J’s 2025 results will be the launching point for its guidance of 5%-7% revenue growth for 2025-30, which is still well ...

Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, ...

Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ ...

Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

In a report released today, Anil Shenoy from Barclays maintained a Buy rating on Elementis (ELM – Research Report), with a price target of ...

Dry shampoo is a must-have beauty product for many Brits, but use it too often and it could seriously damage your hair ...

According to hair experts, the biggest issue with dry shampoo is its potential to clog hair follicles, irritate the scalp and ...

Law & Order actress Mariska Hargitay has the most enviable hair - and we've got Mariska's drugstore beauty secret, a $15 dry ...